ELITE PHARMACEUTICALS, INC /NV/ — Cash Flow Charts
2 years of history · ending 2025-03-31 · SEC EDGAR
Source:10-K · 10-Q
Capital Allocation
How management deploys cash: investing in the business (Capex + M&A) vs returning to shareholders (Buybacks + Dividends).
Capital Allocation Waterfall
Cash Flow
Cash Flow by Activity
Operating Cash Flow
$7M
Free Cash Flow
$6M
Investing Cash Flow
$-2M
Financing Cash Flow
$-826K
Capex
$2M
Stock-Based Comp
—
Debt Issued
—
Debt Repaid
—
D&A
$1M
SBC Allocated Expense
$228K
SBC Unrecognized Cost
$228K